Encompass More Asset Management »

Halozyme Therapeutics shares owned by Encompass More Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Encompass More Asset Management from 13F filings

Historical chart of Encompass More Asset Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Encompass More Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Encompass More Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $288k 3.9k 73.34
2025-03-31 $235k 3.7k 63.81

More positions owned by Encompass More Asset Management

Wisdomtree Tr Floatng Rat Trea (USFR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Northern Lts Fd Tr Iv Main Buywrite (BUYW)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
World Gold Tr Spdr Gld Minis (GLDM)
Etfs Gold Tr Physcl Gold Shs (SGOL)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Select Sector Spdr Tr Technology (XLK)
Starboard Invt Tr Adaptive Alpha (AGOX)
Advisorshares Tr Q Dynamic Growth (QPX)
Innovator Etfs Trust Growth 100 Power (NSEP)
Vaneck Etf Trust Gold Miners Etf (GDX)
Tesla Motors (TSLA)

View all positions for Encompass More Asset Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Arrowstreet Capital, Limited Partnership
Invesco
UBS Group
Snyder Capital Management
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Alliancebernstein
Morgan Stanley
Macquarie Group
Federated Investors
Congress Asset Management

View all funds holding Halozyme Therapeutics